Logo (only for this site): Jhpiego, an affiliate of Johns Hopkins University--Innovating to save lives(logo, continued)(logo, continued)
 
Home About Us What We Do Resources Media Center Careers Donate Contact Us

Home : Media Center : Program Spotlights : Jhpiego's Work in MIP in Nigeria

Two pregnant women sitting in clinic waiting area

Pregnant women at an antenatal care clinic in Akwa Ibom State, Nigeria

MCH Program Spotlight

A few steps forward on a long, winding road: Jhpiego's work in malaria in pregnancy in Nigeria

Each year, thirty million pregnancies are threatened by malaria in endemic countries throughout Africa. Of these, one of the hardest hit is Nigeria, where the disease accounts for 11% of maternal mortality, and 12–30% of mortality in children under five years of age.

Despite the tragedy and economic loss reflected by these percentages, the majority of pregnant women in Nigeria do not have access to the simple technologies that exist to prevent and control malaria in pregnancy (MIP), including: insecticide-treated bednets (ITNs), which work by forming a protective barrier between mosquitoes and women while they sleep; and intermittent preventive treatment (IPT), the drug regimen recommended for protecting women and their unborn babies from the effects of malaria.

One reason is that such interventions have only recently been adopted into Nigeria’s national policy. Another reason is that there is low overall utilization of antenatal care (ANC) services among Nigerian women compared to women in other African countries, and ANC is often regarded as the ideal opportunity for provision of MIP interventions.

How do we ensure that MIP services are included in existing ANC programs, and also made available to hard-to-reach women, like so many in Nigeria? Jhpiego has been working to answer these and other important MIP-related questions for over six years in a total of 24 countries, and is currently building capacity in ANC facilities worldwide.

Through these diverse experiences—and as a MIP leader in the World Health Organization's Roll Back Malaria (RBM) initiative, and one of four partner organizations in the U.S. Agency for International Development's Malaria Action Coalition (MAC)—Jhpiego has emerged as a leader in the area of human capacity development around MIP.

Even with such experience and expertise, however, getting effective MIP programming off the ground is very challenging, largely because of limited funding or funding that targets only part of the problem—according to Dr. William Brieger, Jhpiego’s Senior Malaria Specialist. "Our work in Nigeria perfectly exemplifies the kind of process and commitment needed," Dr. Brieger continues; "You can’t just zoom in, fix the problem and zoom back out again."

Jhpiego began working in MIP in Nigeria in 2003, as part of the MAC. MAC was called upon by USAID/Nigeria to provide technical assistance in support of the country's existing efforts around malaria. After conducting a situational analysis, MAC assisted the National Malaria Control Program of the Federal Ministry of Health, RBM partners and other key stakeholders in developing new MIP policies and guidelines.

Jhpiego played a leading role—per its areas of organizational expertise—in roll-out activities aimed at garnering buy-in among, and educating, service providers. These activities included developing an orientation package, producing a complete curriculum and training package (adapted from Jhpiego’s global malaria package), and conducting workshops and trainings. The new policies and guidelines were adopted by the government of Nigeria in 2005, and Jhpiego conducted an additional follow-up training in early 2006.

Earlier this year, Jhpiego conducted a rapid assessment for ExxonMobil—as part of its Africa Health Initiative—of the MIP situation in Nigeria, Angola, Cameroon, Chad and Equatorial Guinea. The purpose of this activity was to identify a country-specific "roadmap" of future actions—in key areas such as policy, commodities, training, supervision and community awareness of MIP—for the advancement of effective MIP programming. The Nigerian assessment focused on Akwa Ibom State in the southeast, which is not only ExxonMobil's "main footprint" in Nigeria, but is at the same time one of the most highly malaria-endemic areas of the country.

The assessment revealed two major cross-cutting themes in the countries' MIP situations. First, most of the countries, like Nigeria, have MIP policies and guidelines, but they are not being disseminated. Second, even in those countries with high-quality ANC services that are well utilized, ANC is not reaching enough pregnant women early enough in pregnancy so that they can benefit fully from the protection of ITNs and IPT.

But there were also very important differences revealed among the countries. As Dr. Brieger explains, "Although the goal is the same—the prevention and control of malaria in pregnancy—the 'roadmap' is not the same for different countries because each is starting from a different place."

In Nigeria, the assessment revealed especially low availability and uptake of ANC services, and the lack of MIP services in existing ANC programs. It also showed that community members were very aware of the problems malaria can cause in pregnant women, and that they would be supportive of MIP services. "And this points to an area of potential opportunity at the community level,” says Dr. Brieger.

Next steps under consideration for Nigeria, based in part on the ExxonMobil assessment, include using Jhpiego’s Standards-Based Management and Recognition approach to strengthen ANC training, and developing a community-based intervention to get MIP services to hard-to-reach women and link them with ANC services. "The ExxonMobil assessment enabled us to continue important work in the area of MIP in Nigeria, to take important steps in what is certain to be a long journey," Dr. Brieger explains.

As part of MAC, for example, Jhpiego/ACCESS will soon be providing technical assistance to Nigeria's Malaria Global Fund Grant principal recipient (Yakubu Gowon Foundation) and sub-recipient (National Malaria Control Program) to improve planning for and delivery of MIP services. "Our work in Nigeria," says Dr. Brieger, "will help us to establish practical approaches suited for low-resource settings, which will contribute significantly to the global pool of knowledge in MIP."

More Information

For more information about Jhpiego's work in malaria in pregnancy, contact us.

For more information about Jhpiego's activities in Nigeria, contact the Jhpiego/Nigeria Office.

To read other spotlights, go to Program Spotlights.

For additional resources on maternal and child health, browse our Information Sheets and/or go to the MCH section of our Publications Catalog.

Back to top to top of page

HOME    |    ABOUT US    |    CENTERS    |    RESOURCES   |    MEDIA CENTER   |    CAREERS
DONATE    |    CONTACT US

Copyright © 2000-2008 Jhpiego, an affiliate of Johns Hopkins University. All rights reserved.
Web Policy   |   Site Credits   |   Site Map